Paragon 28, Inc. (FNA)
NYSE: FNA · IEX Real-Time Price · USD
6.62
+0.04 (0.61%)
Jul 2, 2024, 4:00 PM EDT - Market closed

Paragon 28 Revenue

Paragon 28 had revenue of $225.44M in the twelve months ending March 31, 2024, with 17.38% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $61.08M with 17.38% year-over-year growth. In the year 2023, Paragon 28 had annual revenue of $216.39M with 19.30% growth.

Revenue (ttm)
$225.44M
Revenue Growth
+17.38%
P/S Ratio
2.44
Revenue / Employee
$392,744
Employees
574
Market Cap
549.14M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023216.39M35.01M19.30%
Dec 31, 2022181.38M33.92M23.00%
Dec 31, 2021147.46M36.48M32.87%
Dec 31, 2020110.98M4.70M4.42%
Dec 31, 2019106.28M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Pharming Group 280.83M
National Research 147.42M
REGENXBIO 86.73M
IRadimed 67.69M
Arbutus Biopharma 12.99M
Revenue Rankings